Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells

Sandra S. Wise, Amie L. Holmes, Michael E Ketterer, Wendy J. Hartsock, Elena Fomchenko, Spiros Katsifis, W. Douglas Thompson, John Pierce Wise

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen with potentially widespread exposure. Solubility is a key factor in the carcinogenicity of Cr(VI), with the water-insoluble or 'particulate' compounds being the more potent carcinogens. Studies have indicated that the component ions are responsible for their clastogenicity, but it is uncertain whether chromium (Cr), lead (Pb) or some combination of the two is responsible for the clastogenic effects. Accordingly, we compared the clastogenicity of lead chromate (LC) with soluble sodium chromate (SC) and lead glutamate (LG) in WTHBF-6 human lung cells. We found that 1436μM was the maximal intracellular level of Pb after exposure to clastogenic concentrations of LC. However, clastogenesis was not observed after exposure to LG, even when intracellular Pb concentrations reached 13,347μM, indicating that intracellular Pb levels did not reach clastogenic levels in WTHBF-6 cells after LC treatment. By contrast, SC was clastogenic damaging 16 and 44% of metaphase cells at intracellular Cr doses of 312 and 1262μM respectively, which was comparable to the clastogenesis observed after LC treatment. LC damaged 10, 27 and 37% of metaphases at intracellular Cr doses of 288, 926 and 1644μM, respectively. These data indicate that with respect to LC-induced clastogenicity, Cr and not Pb is the proximate clastogenic species in human lung cells.

Original languageEnglish (US)
Pages (from-to)79-89
Number of pages11
JournalMutation Research - Genetic Toxicology and Environmental Mutagenesis
Volume560
Issue number1
DOIs
StatePublished - May 9 2004

Fingerprint

Chromium
Metaphase
Carcinogens
Lung
Glutamic Acid
Solubility
lead chromate
Ions
Water
chromium hexavalent ion

Keywords

  • Chromium
  • Chromosomal aberrations
  • Clastogenicity
  • Cytotoxicity
  • Genotoxicity
  • Lead chromate
  • Lung cancer
  • Sodium chromate
  • WTHBF-6 cells

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Genetics

Cite this

Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. / Wise, Sandra S.; Holmes, Amie L.; Ketterer, Michael E; Hartsock, Wendy J.; Fomchenko, Elena; Katsifis, Spiros; Thompson, W. Douglas; Wise, John Pierce.

In: Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 560, No. 1, 09.05.2004, p. 79-89.

Research output: Contribution to journalArticle

Wise, Sandra S. ; Holmes, Amie L. ; Ketterer, Michael E ; Hartsock, Wendy J. ; Fomchenko, Elena ; Katsifis, Spiros ; Thompson, W. Douglas ; Wise, John Pierce. / Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. In: Mutation Research - Genetic Toxicology and Environmental Mutagenesis. 2004 ; Vol. 560, No. 1. pp. 79-89.
@article{4f263334e1134895a94ed649cf65432c,
title = "Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells",
abstract = "Hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen with potentially widespread exposure. Solubility is a key factor in the carcinogenicity of Cr(VI), with the water-insoluble or 'particulate' compounds being the more potent carcinogens. Studies have indicated that the component ions are responsible for their clastogenicity, but it is uncertain whether chromium (Cr), lead (Pb) or some combination of the two is responsible for the clastogenic effects. Accordingly, we compared the clastogenicity of lead chromate (LC) with soluble sodium chromate (SC) and lead glutamate (LG) in WTHBF-6 human lung cells. We found that 1436μM was the maximal intracellular level of Pb after exposure to clastogenic concentrations of LC. However, clastogenesis was not observed after exposure to LG, even when intracellular Pb concentrations reached 13,347μM, indicating that intracellular Pb levels did not reach clastogenic levels in WTHBF-6 cells after LC treatment. By contrast, SC was clastogenic damaging 16 and 44{\%} of metaphase cells at intracellular Cr doses of 312 and 1262μM respectively, which was comparable to the clastogenesis observed after LC treatment. LC damaged 10, 27 and 37{\%} of metaphases at intracellular Cr doses of 288, 926 and 1644μM, respectively. These data indicate that with respect to LC-induced clastogenicity, Cr and not Pb is the proximate clastogenic species in human lung cells.",
keywords = "Chromium, Chromosomal aberrations, Clastogenicity, Cytotoxicity, Genotoxicity, Lead chromate, Lung cancer, Sodium chromate, WTHBF-6 cells",
author = "Wise, {Sandra S.} and Holmes, {Amie L.} and Ketterer, {Michael E} and Hartsock, {Wendy J.} and Elena Fomchenko and Spiros Katsifis and Thompson, {W. Douglas} and Wise, {John Pierce}",
year = "2004",
month = "5",
day = "9",
doi = "10.1016/j.mrgentox.2004.02.009",
language = "English (US)",
volume = "560",
pages = "79--89",
journal = "Mutation Research - Genetic Toxicology and Environmental Mutagenesis",
issn = "1383-5718",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells

AU - Wise, Sandra S.

AU - Holmes, Amie L.

AU - Ketterer, Michael E

AU - Hartsock, Wendy J.

AU - Fomchenko, Elena

AU - Katsifis, Spiros

AU - Thompson, W. Douglas

AU - Wise, John Pierce

PY - 2004/5/9

Y1 - 2004/5/9

N2 - Hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen with potentially widespread exposure. Solubility is a key factor in the carcinogenicity of Cr(VI), with the water-insoluble or 'particulate' compounds being the more potent carcinogens. Studies have indicated that the component ions are responsible for their clastogenicity, but it is uncertain whether chromium (Cr), lead (Pb) or some combination of the two is responsible for the clastogenic effects. Accordingly, we compared the clastogenicity of lead chromate (LC) with soluble sodium chromate (SC) and lead glutamate (LG) in WTHBF-6 human lung cells. We found that 1436μM was the maximal intracellular level of Pb after exposure to clastogenic concentrations of LC. However, clastogenesis was not observed after exposure to LG, even when intracellular Pb concentrations reached 13,347μM, indicating that intracellular Pb levels did not reach clastogenic levels in WTHBF-6 cells after LC treatment. By contrast, SC was clastogenic damaging 16 and 44% of metaphase cells at intracellular Cr doses of 312 and 1262μM respectively, which was comparable to the clastogenesis observed after LC treatment. LC damaged 10, 27 and 37% of metaphases at intracellular Cr doses of 288, 926 and 1644μM, respectively. These data indicate that with respect to LC-induced clastogenicity, Cr and not Pb is the proximate clastogenic species in human lung cells.

AB - Hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen with potentially widespread exposure. Solubility is a key factor in the carcinogenicity of Cr(VI), with the water-insoluble or 'particulate' compounds being the more potent carcinogens. Studies have indicated that the component ions are responsible for their clastogenicity, but it is uncertain whether chromium (Cr), lead (Pb) or some combination of the two is responsible for the clastogenic effects. Accordingly, we compared the clastogenicity of lead chromate (LC) with soluble sodium chromate (SC) and lead glutamate (LG) in WTHBF-6 human lung cells. We found that 1436μM was the maximal intracellular level of Pb after exposure to clastogenic concentrations of LC. However, clastogenesis was not observed after exposure to LG, even when intracellular Pb concentrations reached 13,347μM, indicating that intracellular Pb levels did not reach clastogenic levels in WTHBF-6 cells after LC treatment. By contrast, SC was clastogenic damaging 16 and 44% of metaphase cells at intracellular Cr doses of 312 and 1262μM respectively, which was comparable to the clastogenesis observed after LC treatment. LC damaged 10, 27 and 37% of metaphases at intracellular Cr doses of 288, 926 and 1644μM, respectively. These data indicate that with respect to LC-induced clastogenicity, Cr and not Pb is the proximate clastogenic species in human lung cells.

KW - Chromium

KW - Chromosomal aberrations

KW - Clastogenicity

KW - Cytotoxicity

KW - Genotoxicity

KW - Lead chromate

KW - Lung cancer

KW - Sodium chromate

KW - WTHBF-6 cells

UR - http://www.scopus.com/inward/record.url?scp=4043084819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043084819&partnerID=8YFLogxK

U2 - 10.1016/j.mrgentox.2004.02.009

DO - 10.1016/j.mrgentox.2004.02.009

M3 - Article

VL - 560

SP - 79

EP - 89

JO - Mutation Research - Genetic Toxicology and Environmental Mutagenesis

JF - Mutation Research - Genetic Toxicology and Environmental Mutagenesis

SN - 1383-5718

IS - 1

ER -